Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab for dry AMD
NCT00935883Phase 2Completed
- Sponsor
- Philip J. Rosenfeld
- Start
- Jul 2009
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of eculizumab in age-related macular degeneration (AMD), sponsored by Philip J. Rosenfeld. Started Jul 2009; status: completed.
02
Drugs
eculizumab
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00935883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00935883.